JP2025517106A5 - - Google Patents
Info
- Publication number
- JP2025517106A5 JP2025517106A5 JP2024563976A JP2024563976A JP2025517106A5 JP 2025517106 A5 JP2025517106 A5 JP 2025517106A5 JP 2024563976 A JP2024563976 A JP 2024563976A JP 2024563976 A JP2024563976 A JP 2024563976A JP 2025517106 A5 JP2025517106 A5 JP 2025517106A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- pharmaceutically acceptable
- independently selected
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/089986 | 2022-04-28 | ||
| CN2022089986 | 2022-04-28 | ||
| PCT/CN2023/077272 WO2023207283A1 (en) | 2022-04-28 | 2023-02-20 | Compounds as parp1 inhibitiors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517106A JP2025517106A (ja) | 2025-06-03 |
| JP2025517106A5 true JP2025517106A5 (enExample) | 2026-02-27 |
Family
ID=88517229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563976A Pending JP2025517106A (ja) | 2022-04-28 | 2023-02-20 | Ｐａｒｐ１阻害剤としての化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250289814A1 (enExample) |
| EP (1) | EP4514795A4 (enExample) |
| JP (1) | JP2025517106A (enExample) |
| KR (1) | KR20250033148A (enExample) |
| CN (1) | CN119487027A (enExample) |
| WO (1) | WO2023207283A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120081844A (zh) | 2022-01-21 | 2025-06-03 | 新特拉有限公司 | Parp1抑制剂及其用途 |
| AU2023235233A1 (en) | 2022-03-14 | 2024-09-12 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| AU2023259236B2 (en) | 2022-04-28 | 2025-01-09 | Xinthera, Inc. | Tricyclic parp1 inhibitors and uses thereof |
| CN118119629A (zh) * | 2022-09-30 | 2024-05-31 | 中国医药研究开发中心有限公司 | 含氮杂环类化合物及其医药用途 |
| US20250129051A1 (en) * | 2023-10-23 | 2025-04-24 | Gilead Sciences, Inc. | Parp1 inhibitors and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000016151A (ko) * | 1996-05-29 | 2000-03-25 | 로즈 암스트롱, 크리스틴 에이. 트러트웨인 | 벤족사지논 도파민 d4 수용체 길항제 |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| KR20070027584A (ko) * | 2004-06-17 | 2007-03-09 | 와이어쓰 | 고나도트로핀 방출 호르몬 수용체 길항제 |
| US8404713B2 (en) * | 2007-10-26 | 2013-03-26 | Janssen Pharmaceutica Nv | Quinolinone derivatives as PARP inhibitors |
| UY31603A1 (es) * | 2008-01-23 | 2009-08-31 | Derivados de ftalazinona | |
| WO2010111626A2 (en) * | 2009-03-27 | 2010-09-30 | Takeda Pharmaceutical Company Limited | Poly (adp-ribose) polymerase (parp) inhibitors |
| SI3999506T1 (sl) * | 2019-07-19 | 2025-06-30 | Astrazeneca Ab | Zaviralci PARP1 |
| US11591331B2 (en) * | 2021-04-19 | 2023-02-28 | Xinthera, Inc. | PARP1 inhibitors and uses thereof |
| WO2022228387A1 (en) * | 2021-04-26 | 2022-11-03 | Fochon Biosciences, Ltd. | Compounds as parp inhibitors |
| KR102867210B1 (ko) * | 2021-10-01 | 2025-10-14 | 신테라, 인크. | 아제티딘 및 피롤리딘 parp1 저해제, 및 이의 용도 |
| CN118119629A (zh) * | 2022-09-30 | 2024-05-31 | 中国医药研究开发中心有限公司 | 含氮杂环类化合物及其医药用途 |
-
2023
- 2023-02-20 CN CN202380050136.0A patent/CN119487027A/zh active Pending
- 2023-02-20 WO PCT/CN2023/077272 patent/WO2023207283A1/en not_active Ceased
- 2023-02-20 EP EP23794719.7A patent/EP4514795A4/en active Pending
- 2023-02-20 US US18/861,016 patent/US20250289814A1/en active Pending
- 2023-02-20 JP JP2024563976A patent/JP2025517106A/ja active Pending
- 2023-02-20 KR KR1020247039613A patent/KR20250033148A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025517106A5 (enExample) | ||
| US6762204B2 (en) | Taxol enhancer compounds | |
| EP2799437B1 (en) | Quinoline and cinnoline derivatives and use thereof | |
| KR102796209B1 (ko) | 키나아제 억제제로서의 시클릭 이미노피리미딘 유도체 | |
| TWI773730B (zh) | 治療性樹枝狀聚合物 | |
| EP4001276A1 (en) | Aurora kinase inhibitor and use thereof | |
| RU2005100842A (ru) | Производные 8-гидроксихинолина | |
| CN107382966B (zh) | 一类荜茇酰胺-川芎嗪杂合物、制备方法及医药用途 | |
| JP2017534657A (ja) | 新型シチジン誘導体およびその適用 | |
| AU2019331665A1 (en) | Heterocyclic compounds as AHR modulators | |
| JP2018529643A5 (enExample) | ||
| WO2020181386A1 (en) | Fluorinated benzo[f]benzimidazol-4-9-dione ium derivatives and pharmaceutical compositions thereof and their use as survivin suppressants | |
| CN110128425B (zh) | 作为pi3k/mtor抑制剂的芳环或杂环取代的稠合喹啉化合物 | |
| CN103476769B (zh) | 抗癌剂 | |
| JP2022552019A5 (enExample) | ||
| CN104250253A (zh) | 取代四氢化萘酰胺类化合物及其药学上可接受的盐及制备方法和应用 | |
| WO1996028447A1 (en) | Pyrrolocarbazole derivatives | |
| CN106946868A (zh) | 一氧化氮供体型香豆素衍生物、其制备方法及医药用途 | |
| CA3179325A1 (en) | Kinase inhibitors and uses thereof | |
| CN108707145B (zh) | 含五元杂环结构的喹啉类化合物及其制备和应用 | |
| JP2021534084A5 (enExample) | ||
| AU2015355965B2 (en) | Novel PEG derivative | |
| JP7302090B2 (ja) | ベンゾフラン系ｎ－アシルヒドラゾン誘導体およびそれを含む薬学的組成物 | |
| CN102617502A (zh) | 一类苯并噁唑衍生物及其医药应用 | |
| CN114478534B (zh) | 具有抗肿瘤活性的嵌合分子及其制备方法和应用 |